Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
about
Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapyCombination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation.Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-AnalysisGemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerA study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience.Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Hepatitis B reactivation after chemotherapy: two decades of clinical research.Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients.Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
P2860
Q24240881-B820AA32-7071-4CC3-8BD6-CD7B2E911CC6Q33343777-2DE6BD57-1946-4304-8E25-D59C535528C3Q33623019-F19DA28D-6725-46C8-8F84-251F772A532AQ34394777-7641B076-679B-4962-B235-EC7FE65B2F49Q35152610-F3D5B375-6B3C-4739-8502-DF7CB3B47BD2Q35210407-20787436-7159-4582-AE74-AB48B11EA184Q35658261-232619A1-7577-4926-8ACC-DD1B3CCDB089Q36643732-EB60EBB4-7BFF-428F-AB61-1E4661578339Q36756376-71124B4E-4606-4328-8852-D2AAAC27AED1Q37764963-4835DE53-62FD-4083-BF22-AAB4F7F741F9Q37883147-2E1572E3-37D4-4F32-B3C9-B56427351B21Q37912229-14054EFD-CB64-4E46-AC7C-6177FE42A622Q42590960-31A70CBA-E182-485B-87D8-85012795E9DCQ43831214-FD021E6F-8575-4B51-9959-BE4744E72885Q44548389-C75A984B-9182-4BBE-B02C-E163AA7AEB0FQ45268408-CFE9D1E7-24B0-40D6-8704-D5F8192380BAQ45366737-CF9BB13E-C8B0-45A5-96CA-E40DFF1F21DAQ45367828-8913A114-C2ED-42D9-929C-8C2CDB6A6D6FQ45419941-050E756D-BB8F-4486-A41E-26950E3F9FD9Q46732231-7D3DD159-E602-4583-9DB6-73FFA0CEA85F
P2860
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@en
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@nl
type
label
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@en
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@nl
prefLabel
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@en
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@nl
P2093
P2860
P1476
Lamivudine in the treatment of ...... during cytotoxic chemotherapy.
@en
P2093
Johnson PJ
Steinberg JL
P2860
P304
P356
10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X
P577
1999-11-01T00:00:00Z